LIQUIDIA CORP (LQDA) Fundamental Analysis & Valuation

NASDAQ:LQDA • US53635D2027

Current stock price

38.55 USD
-1.77 (-4.39%)
At close:
38 USD
-0.55 (-1.43%)
After Hours:

This LQDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LQDA Profitability Analysis

1.1 Basic Checks

  • LQDA had negative earnings in the past year.
  • In the past year LQDA has reported a negative cash flow from operations.
  • LQDA had negative earnings in each of the past 5 years.
  • LQDA had a negative operating cash flow in each of the past 5 years.
LQDA Yearly Net Income VS EBIT VS OCF VS FCFLQDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -21.02%, LQDA is in the better half of the industry, outperforming 61.14% of the companies in the same industry.
  • With a Return On Equity value of -154.03%, LQDA is not doing good in the industry: 70.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.02%
ROE -154.03%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LQDA Yearly ROA, ROE, ROICLQDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

  • LQDA has a Gross Margin of 91.64%. This is amongst the best in the industry. LQDA outperforms 93.26% of its industry peers.
  • LQDA's Gross Margin has improved in the last couple of years.
  • LQDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.75%
GM growth 5Y6.28%
LQDA Yearly Profit, Operating, Gross MarginsLQDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. LQDA Health Analysis

2.1 Basic Checks

  • LQDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LQDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LQDA Yearly Shares OutstandingLQDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LQDA Yearly Total Debt VS Total AssetsLQDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 4.99 indicates that LQDA is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of LQDA (4.99) is better than 73.58% of its industry peers.
  • LQDA has a Debt/Equity ratio of 2.97. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 2.97, LQDA is doing worse than 83.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Altman-Z 4.99
ROIC/WACCN/A
WACC9.15%
LQDA Yearly LT Debt VS Equity VS FCFLQDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

2.3 Liquidity

  • A Current Ratio of 2.01 indicates that LQDA has no problem at all paying its short term obligations.
  • LQDA has a Current ratio of 2.01. This is in the lower half of the industry: LQDA underperforms 62.69% of its industry peers.
  • A Quick Ratio of 1.84 indicates that LQDA should not have too much problems paying its short term obligations.
  • LQDA's Quick ratio of 1.84 is on the low side compared to the rest of the industry. LQDA is outperformed by 60.10% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.84
LQDA Yearly Current Assets VS Current LiabilitesLQDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. LQDA Growth Analysis

3.1 Past

  • LQDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.50%, which is quite impressive.
  • Looking at the last year, LQDA shows a very strong growth in Revenue. The Revenue has grown by 1031.18%.
  • The Revenue has been growing by 192.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)51.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.96%
Revenue 1Y (TTM)1031.18%
Revenue growth 3Y114.96%
Revenue growth 5Y192.46%
Sales Q2Q%3054.65%

3.2 Future

  • Based on estimates for the next years, LQDA will show a very strong growth in Earnings Per Share. The EPS will grow by 59.29% on average per year.
  • LQDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.95% yearly.
EPS Next Y433.83%
EPS Next 2Y185.96%
EPS Next 3Y107.54%
EPS Next 5Y59.29%
Revenue Next Year291.99%
Revenue Next 2Y148.18%
Revenue Next 3Y93%
Revenue Next 5Y49.95%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LQDA Yearly Revenue VS EstimatesLQDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
LQDA Yearly EPS VS EstimatesLQDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. LQDA Valuation Analysis

4.1 Price/Earnings Ratio

  • LQDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • LQDA is valuated correctly with a Price/Forward Earnings ratio of 14.26.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LQDA indicates a rather cheap valuation: LQDA is cheaper than 83.42% of the companies listed in the same industry.
  • LQDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE N/A
Fwd PE 14.26
LQDA Price Earnings VS Forward Price EarningsLQDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LQDA Per share dataLQDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • LQDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LQDA's earnings are expected to grow with 107.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y185.96%
EPS Next 3Y107.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LQDA Dividend Analysis

5.1 Amount

  • LQDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LQDA Fundamentals: All Metrics, Ratios and Statistics

LIQUIDIA CORP

NASDAQ:LQDA (4/10/2026, 8:00:01 PM)

After market: 38 -0.55 (-1.43%)

38.55

-1.77 (-4.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05
Earnings (Next)05-07
Inst Owners68.36%
Inst Owner Change0%
Ins Owners4.19%
Ins Owner Change1.57%
Market Cap3.40B
Revenue(TTM)158.32M
Net Income(TTM)-68.92M
Analysts82.67
Price Target51.68 (34.06%)
Short Float %16.33%
Short Ratio7.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.3%
Min EPS beat(2)-7.63%
Max EPS beat(2)90.23%
EPS beat(4)1
Avg EPS beat(4)15.04%
Min EPS beat(4)-11.43%
Max EPS beat(4)90.23%
EPS beat(8)2
Avg EPS beat(8)-1.47%
EPS beat(12)2
Avg EPS beat(12)-18.47%
EPS beat(16)5
Avg EPS beat(16)-10.57%
Revenue beat(2)2
Avg Revenue beat(2)95.44%
Min Revenue beat(2)7.87%
Max Revenue beat(2)183%
Revenue beat(4)3
Avg Revenue beat(4)74.69%
Min Revenue beat(4)-6.33%
Max Revenue beat(4)183%
Revenue beat(8)4
Avg Revenue beat(8)21.18%
Revenue beat(12)6
Avg Revenue beat(12)13.66%
Revenue beat(16)9
Avg Revenue beat(16)13.15%
PT rev (1m)10.95%
PT rev (3m)15.15%
EPS NQ rev (1m)7.74%
EPS NQ rev (3m)7.95%
EPS NY rev (1m)43.55%
EPS NY rev (3m)35.69%
Revenue NQ rev (1m)5.18%
Revenue NQ rev (3m)25.76%
Revenue NY rev (1m)22.83%
Revenue NY rev (3m)45.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.26
P/S 21.45
P/FCF N/A
P/OCF N/A
P/B 75.91
P/tB 89.64
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)2.7
Fwd EY7.01%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS1.8
BVpS0.51
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.02%
ROE -154.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.64%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.75%
GM growth 5Y6.28%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 414.66%
Cap/Sales 4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 1.84
Altman-Z 4.99
F-Score5
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)439.2%
Cap/Depr(5y)267.14%
Cap/Sales(3y)42.98%
Cap/Sales(5y)26.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.96%
EPS Next Y433.83%
EPS Next 2Y185.96%
EPS Next 3Y107.54%
EPS Next 5Y59.29%
Revenue 1Y (TTM)1031.18%
Revenue growth 3Y114.96%
Revenue growth 5Y192.46%
Sales Q2Q%3054.65%
Revenue Next Year291.99%
Revenue Next 2Y148.18%
Revenue Next 3Y93%
Revenue Next 5Y49.95%
EBIT growth 1Y57.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year833.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.8%
OCF growth 3YN/A
OCF growth 5YN/A

LIQUIDIA CORP / LQDA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LIQUIDIA CORP (LQDA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LQDA.


What is the valuation status of LIQUIDIA CORP (LQDA) stock?

ChartMill assigns a valuation rating of 3 / 10 to LIQUIDIA CORP (LQDA). This can be considered as Overvalued.


How profitable is LIQUIDIA CORP (LQDA) stock?

LIQUIDIA CORP (LQDA) has a profitability rating of 2 / 10.